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Background: Liver resection remains major surgery frequently requiring intra-operative blood transfu-
sion. Patients are typically over cross-matched, and with blood donor numbers falling, cross-matching
and transfusion policies need rationalizing.
Aim: To identify predictors of peri-operative blood transfusion.
Methods: A retrospective review of elective hepatic resections over a 4-year period was performed.
Twenty-six variables including clinicopathological variables and intra-operative data were collated,
together with the number of units of blood cross-matched and transfused in the immediate peri-operative
period (48 h). Multivariate regression analysis was performed to identify independent predictors of blood
transfusion, and a Risk Score for transfusion constructed.
Results: Five hundred and eighty-nine patients were included in the study, and were cross-matched with
a median 10 units of blood. Seventeen per cent of patients received a blood transfusion; median
transfusion when required was 2 units. Regression analysis identified seven factors predictive of trans-
fusion: haemoglobin <12.5 g/dL, pre-operative biliary drainage, coronary artery disease, largest tumour
>3.5 cm, cholangiocarcinoma, redo resection and extended resection (5+ segments). Patients were
stratified into high or low risk of transfusion based on Risk Score with a sensitivity of 73% [receiver-
operating characteristic (ROC) 0.77].
Conclusions: Patients undergoing elective liver resection are over-cross-matched. Patients can be
classified into high and low risk of transfusion using a Risk Score, and cross-matched accordingly.
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Introduction
Despite advances in surgical and anaesthetic techniques, blood
transfusion is still required in 10–33% of patients undergoing
elective liver resection.1–5 The risks of transfusion are well docu-
mented and there is evidence that an allogenic blood transfusion
in cancer resections has an adverse immunomodulatory effect
associated with increased risk of tumour recurrence and poor
prognosis.6–15 The safety, efficacy and cost effectiveness of
pre-operative erythropoetin16–18 and autologous blood
donation19–21 as approaches to reducing allogenic blood transfu-
sion are still being debated, and although they form part of a blood
transfusion protocol in many centres their use is not widespread.
In the UK, the number of active blood donors has fallen 20% in
the past 5 years, and with blood stocks consistently below optimal
levels, strategic planning is required to manage available blood
products.22,23 This will assume even greater importance with the
impending introduction of a test for new variant Creutzfeld Jacob
Disease (nvCJD). The personal, financial and social implications
of being tested for nvCJD are expected to deter many potential
and existing donors.
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The purpose of the present study was to identify predictors of
peri-operative blood transfusion in patients undergoing elective
liver resection, and to evaluate whether surgery could safely be
performed with fewer cross-matched units of packed red blood
cells (PRBCs). Pre-operative identification of patients at high risk
of transfusion would allow either cross-matching of additional
units or consideration of further blood conservation strategies for
this group.
Methods
All patients undergoing elective liver resections in a tertiary
referral HPB unit since January 1993 have been prospectively
maintained on an electronic database. A contemporary cohort of
patients recruited between September 2004 and March 2008 were
identified. Pre-operative clinicopathological data were collated,
including age, comorbidities, pre-operative haemoglobin, pre-
operative prothrombin time, pre-operative platelet count, pre-
vious liver surgery or tumour ablation, adjuvant or neoadjuvant
chemotherapy or radiotherapy, number of tumours, size of the
largest tumour and the presence of underlying hepatic steatosis
or fibrosis.
Parenchymal transection was performed using the Cavi-Pulse
Ultrasonic Surgical Aspirator (CUSA, Model 200T; Valley Labo-
ratory, Boulder, CO, USA). Intermittent Pringle manoeuvre when
required was with a 10-min on, 5-min off cycle. Haemostasis of
the liver cut surface was achieved with either argon diathermy
alone, or with the addition of haemostatic adjuncts such as Tacho-
Sil (Nycomed, Copenhagen, Denmark) or Tisseel fibrin glue
(Baxter Healthcare Corporation, Glendale, CA, USA). Where mul-
tiple resections were performed at the same time, the most exten-
sive resection was considered the main procedure, and additional
procedures (excluding metastatectomy and radiofrequency
ablation) were listed as such. The total number of hepatic
(Couinaud’s) segments resected was determined by the procedure
performed as stated in the Brisbane nomenclature.24 Additional
intra-operative data included operation performed, whether
resection was performed open or laparoscopic, use of the Pringle
manoeuvre and whether haemostatic agents were used on the cut
liver surface. Histological diagnosis was corroborated with histo-
pathology reports for each patient.
The number of units of PRBCs cross-matched for each patient,
and the number of units transfused in the peri-operative period,
taken as 48 h from time of surgery, was identified from the hos-
pital’s transfusion service electronic records. Threshold for trans-
fusion was haemoglobin less than 8 g/dL, or less than 10 g/dL in
patients with coronary artery disease or symptomatic anaemia.
Patients were routinely cross-matched for 5 units of PRBCs from
March 2007, and 10 units PRBCs prior to this.
Statistical analysis
Statistical analysis was performed using SPSS version 16.0 (SPSS
Inc., Chicago, IL, USA). The mean number of units cross-matched
and transfused per patient was calculated and stratified by
operation performed. To determine factors associated with blood
transfusion, continuous variables were evaluated using the inde-
pendent sample t-test, categorical variables using c2 and ordinal
data using Kruskal–Wallis tests. All variables significant at P < 0.05
on univariate analysis were entered into a forward stepwise logistic
multiple regression analysis. Significance was set at P < 0.05. The
overall fit of the model to the data was assessed using the Hosmer–
Lemeshow goodness-of-fit statistic (larger P-values imply better
fit).
Variables remaining significant were used to construct a Risk
Score for predicting the risk of peri-operative blood transfusion.
The Risk Score was compared with patients’ transfusion status
and peri-operative blood requirement. The ability of the score to
discriminate those patients requiring peri-operative blood trans-
fusion was assessed by the area under the receiver-operating char-
acteristic curve (ROC), where an area of 0.5 indicates no
discrimination and an area of 1.0 indicates perfect discrimination.
Results
During the period of study, a total of 589 patients underwent
elective liver resection, with 365 males and 224 females (male/
female ratio 8:5). Median age was 64 years (range 20–91). Types of
resection are outlined in Table 1. Four hundred and thirty-five
(74%) patients had a resection for metastatic disease, 54 (9%) for
hepatocellular carcinoma, 46 (8%) for cholangiocarcinoma, 49
(8%) for benign disease and 5 (1%) for other pathologies: biliary
papillomatosis (2), spindle cell mesenchymal tumour (2) and a
mucinous tumour of indeterminate origin.
A total of 4714 units PRBCs were cross-matched pre-
operatively (median 10 units per patient). Median pre-operative
haemoglobin was 13.6 g/dl. In the peri-operative period, 100
patients (17%) received 420 units PRBCs, with a median transfu-
sion of 2 units. The ratio of units cross-matched to units trans-
Table 1 Transfusion rates by operation. Units transfused relates only








Metastatectomy 204 15% 2
Left lateral hepatectomy 64 13% 2
Left hemihepatectomy 36 14% 3
Left trisectionectomy 17 59% 3
Right hemihepatectomy 158 12% 2
Right trisectionectomy 47 40% 5




Caudate resection 5 0% 0
OVERALL 589 17% 2 (1–41)
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fused was 11 : 1. Transfusion rate and volume varied by type of
operation (see Table 1). Of the 4714 units cross-matched in our
study, only 8.9% were used. The remaining 91.1% were returned
to stock. It was not feasible to track subsequent usage of returned
units for other patients, but the overall wastage rate of packed red
cells in our hospital in the last financial quarter (2008/2009) was
1.63%.
Univariate analysis identified 11 variables predictive of peri-
operative PRBC transfusion (see Table 2). Seven factors remained
independently significant after logistic regression analysis: coro-
nary artery disease, pre-operative biliary drainage, previous liver
resection, pre-operative haemoglobin <12.5 g/dl, tumour size
>3.5 cm, extended resection (5 segments) and a histological
diagnosis of cholangiocarcinoma (see Table 3). The regression
model showed no lack of fit to the data (Hosmer–Lemeshow
0.800), and good discrimination of patients requiring a peri-
operative transfusion (ROC 0.777).
All significant variables on multivariate analysis were deemed
to be of equal importance in predicting peri-operative blood
transfusion on the basis of similar odds ratios. To construct a Risk
Score for peri-operative blood transfusion, each variable was
assigned a score of 1 point, giving a Risk Score range of 0–7. The
proportion of patients requiring transfusion by Risk Score and the
number of units transfused when required is shown in Table 4.
The Risk Score gives good discrimination of patients requiring
a transfusion (ROC 0.77, standard error 0.03). Of patients trans-
fused, the number of units transfused correlated significantly with
Risk Score (P < 0.001, bivariate Spearman’s rank correlation).
Patients were stratified into those at low risk of transfusion (Risk
Score <2) and those at high risk (Risk Score 2). Of the 100
patients transfused, 73% were in the high-risk group (sensitivity
73%, negative predictive value 92%). Thirty-two per cent of the
232 patients in the high-risk group were transfused (median 3
units; range 1–41 units) compared with only 7.5 % of the 375
patients in the low-risk group (median 2 units; range 1–3 units).
Discussion
In the United Kingdom, the number of blood donors has fallen by
20% in the past 5 years, and stocks of donated blood are frequently
below the optimal targets set out by the National Health Service
Blood and Transplant Service (NHSBT). If trends continue,
despite the current decline in demand for blood products, there
will a predicted shortfall of 100 000–300 000 units by 2011/
2012.22,23
A cross-matching policy for liver resection in our unit histori-
cally mirrored that for our liver transplantations, which was
reduced from 10 to 5 units in March 2007 after an audit of trans-
plantation blood usage. This resulted in over-cross-matching of
liver resection patients, as evidenced by the low transfusion rate
and high cross-match to transfusion ratio in this study. Our trans-
fusion rate of 17%, with a median transfusion of 2 units in those
patients transfused, is comparable to contemporary published
results for liver resection.24,25 The British Committee for Standards
in Haematology (BCSH)26 still advocates Friedman’s recommen-
dation in 197627 that the ratio of cross-matched to transfused
PRBCs in surgery should be 2:1, but this is less applicable to liver








Age (mean) 63 60 0.053
Sex = male 308 57 0.261
= female 181 43
Coronary artery disease 54 20 0.014*
Respiratory disease 21 7 0.247
Peripheral vascular disease 20 4 0.967
Diabetes Mellitus 30 7 0.745
Previous tumour ablation 6 4 0.050*
Preoperative biliary drainage 15 15 <0.001*
Previous liver resection 66 22 0.030*
Neoadjuvant chemotherapy 86 76 0.591†
Underlying steatosis 220 36 0.098
Underlying fibrosis 80 23 0.111
Tumour size >3.5 cm 217 62 0.001*
Number of tumours (mean) 2.4 2.1 0.073
Bilateral resections 88 12 0.072
Haemoglobin <12.5 g/dl 107 47 <0.001*
Platelet count <150 ¥ 109 25 8 0.253
Prothrombin time >15 s 35 15 0.010*
Additional procedures 17 10 0.014*
Laparoscopic resection 27 0 0.016*
Use of Pringle manoeuvre 341 67 0.589
Use of haemostatic adjuncts 339 71 0.740
Histological diagnosis
(p value compared to all other diagnoses)
Metastatic disease 374 61 0.001††*
Hepatocellular carcimona41 41 13 0.145
Cholangiocarcinoma 24 22 <0.001*
Benign 47 2 0.012††
Other 3 2 0.169
Extent of resection
(p value compared to minor resection)
1–2 segments (minor) 233 37 –
3–4 segments (major) 180 25 0.629
5 segments (extended) 76 38 <0.001†††*
†Data only available for 477 of 589 patients.
††Metastatic and benign disease significantly predict not requiring blood
transfusion.
†††Extended resection significantly predicts transfusion at p < 0.001
when compared to both minor and major resections.
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resections where despite a modest risk of transfusion the potential
for substantial bleeding is high compared with other operative
procedures.
The Maximal Surgical Blood Order Schedule (MSBOS) is
widely used to guide use of blood components, but MSBOS poli-
cies vary between hospitals and do not take account of patient-
specific factors. A number of studies have attempted to formulate
more patient-specific tools for predicting blood transfusion,28,29
but none have been readily adopted for liver resection patients.
There is no clear consensus of blood transfusion predictors from
the few studies in liver surgery patients.24,25,30 We have demon-
strated that the risk of peri-operative blood transfusion in elective
liver resection can be predicted from seven variables.
Low pre-operative haemoglobin is the most obvious predictor
for peri-operative transfusion, and has been shown in a number of
other studies. Previous liver resection, however, was the strongest
predictor of transfusion, and may relate to the technical difficul-
ties of redo liver surgery.
It is well known that hilar cholangiocarcinoma resections
involve more technically demanding procedures which may
include lymph node dissection, caudate resection, and resection
and reconstruction of hepatic inflow, increasing the likelihood of
blood loss. The extent of liver resection and size of the largest
tumour were predictive of peri-operative blood transfusion in
both this study and other studies.2,4 Larger lesions are generally
more vascularized, and encroachment onto venous outflow causes
more parenchymal congestion.
Patients requiring pre-operative biliary drainage (after endo-
scopic retrograde cholangiopancreatography or percutaneous
transhepatic cholangiography) will have had varying degrees of
biliary obstruction and underlying liver dysfunction. Studies have
shown no independent association between pre-operative biliru-
bin, alkaline phosphatase or alanine aminotransferase and blood
transfusion requirement. The significance of pre-operative biliary
drainage may reflect underlying liver dysfunction and coagulopa-
thy. Although not significant in this study, prothrombin time has
been identified as an independent predictor in other studies.2
Coronary artery disease can affect the patient’s tolerance of
anaemia, low central venous pressure anaesthesia and hypovol-
aemia. We acknowledge that the lower transfusion threshold for
these patients may bias the association with peri-operative trans-
fusion, but for the purpose of predicting transfusion and guiding
preoperative cross-matching, it remains a valid and important
variable in the model.
A similar study by Pulitano et al.4 identified five predictors of
peri-operative transfusion. Their Transfusion Risk Score had a
sensitivity of 94% but their transfusion rate of 33% is almost
double that in the present study. It is not clear how comparably
this score would predict transfusion in cohorts of patients with
lower transfusion rates. We advocate using the Risk Score to
stratify patients into low- and high-risk groups pre-operatively.
Low-risk patients should be group and saved rather than cross-
matched, based on the low risk of transfusion (7.5%) and median
transfusion when required of only 2 units (range 1–3 units). High-
risk patients should be cross-matched 3 units, given that this was
the median transfusion when required and that most blood trans-
fusion services are able to electronically issue further blood within
5 min. Although we were not able to determine when in the 48-h
peri-operative period blood was given, from experience it is most
often given post-operatively. It may be that cross-matching fewer
than 3 units is sufficient for patients in the high-risk group.
There is a financial advantage to reducing routine cross-
matching. The cost of purchasing 1 unit packed red cells in 2007/
2008 was £133.99. The cost of group and saving is £24 per sample
and the cost of cross-matching is approximately £7 per unit. Based
on 250 cases per annum and the 60 : 40 ratio of low-/high-risk
patients observed in this study, the proposed reduction in cross-
matching would save 1050 units of blood, with a cost saving of
£7350 per annum. The actual cost of purchasing blood (£133.99)
is only of significance when considering blood wastage. At an
estimated surgical wastage of 2% of units cross-matched, reducing
this policy would save 21 units per annum, with a further cost
saving of £2814. This is particularly important in circumstances
where unused cross-matched blood returned to stock is less likely
to be reused, such as in smaller hospitals or for less common blood
groups [e.g. group B Rh (D) Negative] where the blood is not held
in local stock in high volume and may have to be ordered specifi-
cally for that patient.
There is also an important strategic benefit to reducing routine
cross-matching of blood, the financial implications of which are
Table 3 Variables independently predictive of perioperative blood
transfusion on multivariate regression analysis
Variable p-value Odds
Ratio
Coronary artery disease 0.018 2.135
Preoperative biliary drainage 0.013 3.925
Redo resection <0.001 4.488
Tumour size >3.5 cm <0.001 2.596
Haemoglobin <12.5 g/dl <0.001 3.661
Extended resection (5+ segments) 0.001 2.603
Histological diagnosis = Cholangiocarcinoma 0.012 3.097
Table 4 Transfusion rates by Risk Score. Units transfused calculated








0 120 5 (4%) 2 (2–3)
1 237 22 (9%) 2 (1–3)
2 149 28 (18%) 3 (2–22)
3 59 25 (42%) 3 (1–41)
4 20 16 (80%) 4 (1–20)
5 4 4 (100%) 3 (2–5)
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harder to discern. In the UK, blood components, products and
services are processed and administered nationally by the NHSBT.
Hospital Trusts purchase blood components to be held locally in
their ‘blood banks’. Reducing the amount of blood cross-matched,
and thereby taken out of a hospital’s available blood stock, allows
transfusion services to operate with lower baseline blood stocks to
meet local demand. From a national perspective this reduces
demand for blood from NHSBT and reduces absolute wastage.
Reducing demand for blood is important when national stock
levels are low and will become a more pressing issue in the near
future, with an anticipated sharp fall in blood donors when tests
for nvCJD are inevitably introduced for blood donation.
The economic arguments for reducing pre-operative cross-
matching must be weighed against patient safety. In advocating
reducing cross-matching to ‘group and save’ for low-risk patients
to 3 units for high-risk patients, the hospital’s blood transfusion
service must be aware of any abnormal antibodies that would
either prolong cross-matching or necessitate the ordering in of
compatible blood components. Our Unit is advised to send
two preoperative ‘group and save’ samples to ensure this, a second
sample being particularly important if there is a large delay
between the preassessment clinic and operation date. In addition,
good communication with the transfusion service and reliable
and timely transport of blood from laboratory to operating
theatres are essential.
In conclusion, this study has demonstrated that blood transfu-
sion in elective liver resection can be predicted from seven vari-
ables. Cross-matching can be guided by use of a Risk Score,
facilitating strategic and cost-effective use of blood. The Risk
Score could also guide the use of other blood conservation strat-
egies. Further work is required to prospectively validate the Risk
Score, evaluate its transferability to other patient populations, and
assess its benefit to the blood transfusion service with respect to
management of blood stocks.
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